Laboratory and clinical study of balofloxacin (Q-35), a new fluoroquinolone, in urinary tract infection.
Suzuki
K
K
Department of Urology, Hiratsuka City Hospital, Kanagawa, Japan.
Horiba
M
M
Ishikawa
K
K
Katoh
S
S
Naide
Y
Y
Yanaoka
M
M
Andoh
S
S
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004058:Diffusion; D013293:Enterococcus faecalis / Q000187:drug effects; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D011467:Prostate / Q000378:metabolism; D015363:Quinolones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015610:Serum Bactericidal Test; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C077155:balofloxacin